Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data

Abstract In this commentary, we review clinical data which helps inform individualized benefit–risk assessment for tofacitinib in patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS). ORAL Surveillance, a safety trial of patients ≥ 50 years of age with rheumatoid arthritis (RA) an...

Полное описание

Библиографические подробности

Главные авторы:	Lars Erik Kristensen, Atul Deodhar, Ying-Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D. Kinch, Dafna D. Gladman
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Adis, Springer Healthcare 2024-05-01
Серии:	Rheumatology and Therapy
Предметы:	Age Ankylosing spondylitis Cardiovascular disease Psoriatic arthritis Tofacitinib Smoking
Online-ссылка:	https://doi.org/10.1007/s40744-024-00662-5
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!